{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:20:47Z","timestamp":1778775647180,"version":"3.51.4"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81072465"],"award-info":[{"award-number":["81072465"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81571579"],"award-info":[{"award-number":["81571579"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s11481-021-10030-7","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T18:02:46Z","timestamp":1635530566000},"page":"437-452","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Increased Expression of CD95 in CD4+ Effector Memory T Cells Promotes Th17 Response in Patients with Myasthenia Gravis"],"prefix":"10.1007","volume":"17","author":[{"given":"Xiaoyu","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengzhan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6422-8491","authenticated-orcid":false,"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linlin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenghua","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deqin","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,29]]},"reference":[{"key":"10030_CR1","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.cyto.2017.05.008","volume":"96","author":"G Aguilo-Seara","year":"2017","unstructured":"Aguilo-Seara G, Xie Y, Sheehan J, Kusner LL, Kaminski HJ (2017) Ablation of IL-17 expression moderates experimental autoimmune myasthenia gravis disease severity. Cytokine 96:279\u2013285","journal-title":"Cytokine"},{"issue":"4","key":"10030_CR2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.sjbs.2015.02.011","volume":"22","author":"AM Aldahlawi","year":"2015","unstructured":"Aldahlawi AM, Elshal MF, Ashgan FT, Bahlas S (2015) Chemokine receptors expression on peripheral CD4-lymphocytes in rheumatoid arthritis: Coexpression of CCR7 and CD95 is associated with disease activity. Saudi J Biol Sci 22(4):453\u2013458","journal-title":"Saudi J Biol Sci"},{"issue":"1","key":"10030_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.sjbs.2015.05.003","volume":"23","author":"AM Aldahlawi","year":"2016","unstructured":"Aldahlawi AM, Elshal MF, Damiaiti LA, Damanhori LH, Bahlas SM (2016) Analysis of CD95 and CCR7 expression on circulating CD4(+) lymphocytes revealed disparate immunoregulatory potentials in systemic lupus erythematosus. Saudi J Biol Sci 23(1):101\u2013107","journal-title":"Saudi J Biol Sci"},{"issue":"6","key":"10030_CR4","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1084\/jem.178.6.2231","volume":"178","author":"MR Alderson","year":"1993","unstructured":"Alderson MR, Armitage RJ, Maraskovsky E, Tough TW, Roux E, Schooley K, Ramsdell F, Lynch DH (1993) Fas transduces activation signals in normal human T lymphocytes. J Exp Med 178(6):2231\u20132235","journal-title":"J Exp Med"},{"issue":"12","key":"10030_CR5","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1002\/(SICI)1521-4141(199912)29:12<3987::AID-IMMU3987>3.0.CO;2-4","volume":"29","author":"L Arlettaz","year":"2015","unstructured":"Arlettaz L, Barbey C, Dumont-Girard F, Helg C, Chapuis B, Roux E, Roosnek E (2015) CD45 isoform phenotypes of human T cells: CD4+CD45RA\u2013RO+ memory T cells re-acquire CD45RA without losing CD45RO. Eur J Immunol 29(12):3987\u20133994","journal-title":"Eur J Immunol"},{"key":"10030_CR6","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/j.1749-6632.1998.tb11015.x","volume":"841","author":"Barohn RJ, McIntire D, Herbelin L, Wolfe GI, Nations S, Bryan WW","year":"1998","unstructured":"Barohn RJ, McIntire D, Herbelin L, Wolfe GI, Nations S, Bryan WW (1998) Reliability testing of the quantitative myasthenia gravis score. Ann N Y Acad Sci 841:769\u2013772","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10030_CR7","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.humimm.2012.02.025","volume":"73","author":"E Boggio","year":"2012","unstructured":"Boggio E, Melensi M, Bocca S, Chiocchetti A, Comi C, Clemente N, Orilieri E, Soluri MF, D\u2019Alfonso S, Mechelli R, Gentile G, Poggi A, Salvetti M, Ramenghi U, Dianzani U (2012) The -346T polymorphism of the SH2D1A gene is a risk factor for development of autoimmunity\/lymphoproliferation in males with defective Fas function. Hum Immunol 73(5):585\u2013592","journal-title":"Hum Immunol"},{"issue":"8","key":"10030_CR8","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1182\/blood-2013-07-518167","volume":"123","author":"E Boggio","year":"2014","unstructured":"Boggio E, Clemente N, Mondino A, Cappellano G, Orilieri E, Gigliotti CL, Toth E, Ramenghi U, Dianzani U, Chiocchetti A (2014) IL-17 protects T cells from apoptosis and contributes to development of ALPS-like phenotypes. Blood 123(8):1178\u20131186","journal-title":"Blood"},{"issue":"2","key":"10030_CR9","doi-asserted-by":"publisher","first-page":"R36","DOI":"10.1186\/ar2390","volume":"10","author":"FM Brennan","year":"2008","unstructured":"Brennan FM, Smith NM, Owen S, Li C, Amjadi P, Green P, Andersson A, Palfreeman AC, Hillyer P, Foey A, Beech JT, Feldmann M (2008) Resting CD4+ effector memory T cells are precursors of bystander-activated effectors: a surrogate model of rheumatoid arthritis synovial T-cell function. Arthritis Res Ther 10(2):R36","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10030_CR10","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S0952-7915(99)00037-0","volume":"11","author":"AV Chervonsky","year":"1999","unstructured":"Chervonsky AV (1999) Apoptotic and effector pathways in autoimmunity. Curr Opin Immunol 11(6):684\u2013688","journal-title":"Curr Opin Immunol"},{"key":"10030_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jaut.2016.10.003","volume":"77","author":"BK Chung","year":"2017","unstructured":"Chung BK, Guevel BT, Reynolds GM, Gupta Udatha DB, Henriksen EK, Stamataki Z, Hirschfield GM, Karlsen TH, Liaskou E (2017) Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis. J Autoimmun 77:45\u201354","journal-title":"J Autoimmun"},{"issue":"5","key":"10030_CR12","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.4049\/jimmunol.1501339","volume":"196","author":"Y Cao","year":"2016","unstructured":"Cao Y, Amezquita RA, Kleinstein SH, Stathopoulos P, Nowak RJ, O\u2019Connor KC (2016) Autoreactive T Cells from Patients with Myasthenia Gravis Are Characterized by Elevated IL-17, IFN-\u03b3, and GM-CSF and Diminished IL-10 Production. J Immunol 196(5):2075\u20132084","journal-title":"J Immunol"},{"issue":"7","key":"10030_CR13","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1212\/WNL.55.7.921","volume":"55","author":"C Comi","year":"2000","unstructured":"Comi C, Leone M, Bonissoni S, DeFranco S, Bottarel F, Mezzatesta C, Chiocchetti A, Perla F, Monaco F, Dianzani U (2000) Defective T cell fas function in patients with multiple sclerosis. Neurology 55(7):921\u2013927","journal-title":"Neurology"},{"issue":"1","key":"10030_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1085-9489.2006.00063.x","volume":"11","author":"C Comi","year":"2006","unstructured":"Comi C, Gaviani P, Leone M, Ferretti M, Castelli L, Mesturini R, Ubezio G, Chiocchetti A, Osio M, Muscia F, Bogliun G, Corso G, Gavazzi A, Mariani C, Cantello R, Monaco F, Dianzani U (2006) Fas-mediated T-cell apoptosis is impaired in patients with chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst 11(1):53\u201360","journal-title":"J Peripher Nerv Syst"},{"key":"10030_CR15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1196\/annals.1405.042","volume":"1132","author":"BM Conti-Fine","year":"2010","unstructured":"Conti-Fine BM, Milani M, Wang W (2010) CD4+ T cells and cytokines in the pathogenesis of acquired myasthenia gravis. Ann N Y Acad Sci 1132:193\u2013209","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10030_CR16","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2337\/diabetes.50.3.483","volume":"50","author":"S DeFranco","year":"2001","unstructured":"DeFranco S, Bonissoni S, Cerutti F, Bona G, Bottarel F, Cadario F, Brusco A, Loffredo G, Rabbone I, Corrias A, Pignata C, Ramenghi U, Dianzani U (2001) Defective function of Fas in patients with type 1 diabetes associated with other autoimmune diseases. Diabetes 50(3):483\u2013488","journal-title":"Diabetes"},{"issue":"25","key":"10030_CR17","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1016\/S0024-3205(03)00196-6","volume":"72","author":"U Dianzani","year":"2003","unstructured":"Dianzani U, Chiocchetti A, Ramenghi U (2003) Role of inherited defects decreasing Fas function in autoimmunity. Life Sci 72(25):2803\u20132824","journal-title":"Life Sci"},{"key":"10030_CR18","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","volume":"330","author":"DB Drachman","year":"1994","unstructured":"Drachman DB (1994) Medical progress: myasthenia gravis. N Engl J Med 330:1797\u20131810","journal-title":"N Engl J Med"},{"key":"10030_CR19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/ICU.0000000000000526","volume":"29","author":"E Fortin","year":"2018","unstructured":"Fortin E, Cestari DM, Weinberg DH (2018) Ocular myasthenia gravis: an update on diagnosis and treatment. Curr Opin Ophthalmol 29:477\u2013484","journal-title":"Curr Opin Ophthalmol"},{"issue":"7","key":"10030_CR20","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1002\/art.21943","volume":"54","author":"RD Fritsch","year":"2006","unstructured":"Fritsch RD, Shen X, Illei GG, Yarboro CH, Prussin C, Hathcock KS, Hodes RJ, Lipsky PE (2006) Abnormal differentiation of memory T cells in systemic lupus erythematosus. Arthritis Rheum 54(7):2184\u20132197","journal-title":"Arthritis Rheum"},{"key":"10030_CR21","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1056\/NEJMra1602678","volume":"375","author":"NE Gilhus","year":"2016","unstructured":"Gilhus NE (2016) Myasthenia Gravis. N Engl J Med 375:2570\u20132581","journal-title":"N Engl J Med"},{"issue":"1","key":"10030_CR22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","volume":"5","author":"NE Gilhus","year":"2019","unstructured":"Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM, Verschuuren JJGM (2019) Myasthenia Gravis Nat Rev Dis Primers 5(1):30","journal-title":"Myasthenia Gravis Nat Rev Dis Primers"},{"issue":"5\u20136","key":"10030_CR23","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3109\/08916930903555943","volume":"43","author":"AM Gomez","year":"2010","unstructured":"Gomez AM, Van Den Broeck J, Vrolix K, Janssen SP, Lemmens MA, Van Der Esch E, Duimel H, Frederik P, Molenaar PC, Mart\u00ednez-Mart\u00ednez P, De Baets MH, Losen M (2010) Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction. Autoimmunity 43(5\u20136):353\u2013370","journal-title":"Autoimmunity"},{"issue":"4","key":"10030_CR24","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/imm.12929","volume":"154","author":"JI Gray","year":"2018","unstructured":"Gray JI, Westerhof LM, MacLeod MKL (2018) The roles of resident, central and effector memory CD4 T-cells in protective immunity following infection or vaccination. Immunology 154(4):574\u2013581","journal-title":"Immunology"},{"key":"10030_CR25","doi-asserted-by":"crossref","unstructured":"Gu\u00e9gan JP, Legembre P (2018) Nonapoptotic functions of Fas\/CD95 in the immune response. FEBS J285(5):809\u2013827","DOI":"10.1111\/febs.14292"},{"issue":"1","key":"10030_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4049\/jimmunol.170.1.28","volume":"170","author":"RL Hengel","year":"2003","unstructured":"Hengel RL, Thaker V, Pavlick MV, Metcalf JA, Dennis G Jr, Yang J, Lempicki RA, Sereti I, Lane HC (2003) Cutting edge: L-selectin (CD62L) expression distinguishes small resting memory CD4+ T cells that preferentially respond to recall antigen. J Immunol 170(1):28\u201332","journal-title":"J Immunol"},{"issue":"2","key":"10030_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ncl.2018.01.002","volume":"36","author":"MK Hehir","year":"2018","unstructured":"Hehir MK, Silvestri NJ (2018) Generalized Myasthenia Gravis: Classification, Clinical Presentation, Natural History, and Epidemiology. Neurol Clin 36(2):253\u2013260","journal-title":"Neurol Clin"},{"issue":"3","key":"10030_CR28","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/85520","volume":"7","author":"W Hoch","year":"2001","unstructured":"Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A (2001) Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 7(3):365\u2013368","journal-title":"Nat Med"},{"issue":"2","key":"10030_CR29","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/ni1552","volume":"9","author":"HC Hsu","year":"2008","unstructured":"Hsu HC, Yang P, Wang J, Wu Q, Myers R, Chen J, Yi J, Guentert T, Tousson A, Stanus AL, Le TV, Lorenz RG, Xu H, Kolls JK, Carter RH, Chaplin DD, Williams RW, Mountz JD (2008) Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 9(2):166\u2013175","journal-title":"Nat Immunol"},{"key":"10030_CR30","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.intimp.2018.11.031","volume":"66","author":"X Huang","year":"2019","unstructured":"Huang X, Yu P, Liu M, Deng Y, Dong Y, Liu Q, Zhang J, Wu T (2019) ERK inhibitor JSI287 alleviates imiquimod-induced mice skin lesions by ERK\/IL-17 signaling pathway. Int Immunopharmacol 66:236\u2013241","journal-title":"Int Immunopharmacol"},{"key":"10030_CR31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/WNL.55.1.16","volume":"55","author":"A Jaretzki 3rd","year":"2000","unstructured":"Jaretzki A 3rd, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, Sanders DB (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55:16\u201323","journal-title":"Neurology"},{"key":"10030_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jneuroim.2015.03.023","volume":"283","author":"J Klehmet","year":"2015","unstructured":"Klehmet J, Staudt M, Ulm L, Unterwalder N, Meisel A, Meisel C (2015) Circulating lymphocyte and T memory subsets in glucocorticosteroid versus IVIG treated patients with CIDP. J Neuroimmunol 283:17\u201322","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10030_CR33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0092-8674(04)00335-6","volume":"117","author":"C King","year":"2004","unstructured":"King C, Ilic A, Koelsch K, Sarvetnick N (2004) Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117(2):265\u2013277","journal-title":"Cell"},{"key":"10030_CR34","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/cells8070671","volume":"8","author":"I Koneczny","year":"2019","unstructured":"Koneczny I, Herbst R (2019) Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture. Cells 8:2\u201335","journal-title":"Cells"},{"issue":"1","key":"10030_CR35","first-page":"32","volume":"54","author":"J Kosalka","year":"2016","unstructured":"Kosalka J, Jakiela B, Musial J (2016) Changes of memory B- and T-cell subsets in lupus nephritis patients. Folia Histochem Cytobiol 54(1):32\u201341","journal-title":"Folia Histochem Cytobiol"},{"issue":"18","key":"10030_CR36","doi-asserted-by":"publisher","first-page":"13664","DOI":"10.1074\/jbc.M700434200","volume":"282","author":"IN Lavrik","year":"2007","unstructured":"Lavrik IN, Golks A, Riess D, Bentele M, Eils R, Krammer PH (2007) Analysis of CD95 threshold signaling: triggering of CD95 (FAS\/APO-1) at low concentrations primarily results in survival signaling. J Biol Chem 282(18):13664\u201313671","journal-title":"J Biol Chem"},{"key":"10030_CR37","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.3389\/fimmu.2017.01216","volume":"8","author":"M Le Gallo","year":"2017","unstructured":"Le Gallo M, Poissonnier A, Blanco P, Legembre P (2017) CD95\/Fas, Non-Apoptotic Signaling Pathways, and Kinases. Front Immunol 8:1216","journal-title":"Front Immunol"},{"issue":"1","key":"10030_CR38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cellimm.2011.06.019","volume":"271","author":"SM Lee","year":"2011","unstructured":"Lee SM, Kim EJ, Suk K, Lee WH (2011) Stimulation of Fas (CD95) induces production of pro-inflammatory mediators through ERK\/JNK-dependent activation of NF-\u03baB in THP-1 cells. Cell Immunol 271(1):157\u2013162","journal-title":"Cell Immunol"},{"issue":"2","key":"10030_CR39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.cellimm.2014.07.004","volume":"290","author":"X Li","year":"2014","unstructured":"Li X, Zhang Z, Peng A, He M, Xu J, Shen S, Zhuang J, Huang X (2014) Effect of CD95 on inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes. Cell Immunol 290(2):209\u2013216","journal-title":"Cell Immunol"},{"issue":"12","key":"10030_CR40","doi-asserted-by":"publisher","first-page":"7948","DOI":"10.4049\/jimmunol.180.12.7948","volume":"180","author":"H Liu","year":"2008","unstructured":"Liu H, Rohowsky-Kochan C (2008) Regulation of IL-17 in human CCR6+ effector memory T cells. J Immunol 180(12):7948\u20137957","journal-title":"J Immunol"},{"key":"10030_CR41","doi-asserted-by":"crossref","unstructured":"Liu X, Ma Q, Qiu L, Ou C, Lin Z, Lu Y, Huang H, Chen P, Huang Z, Liu W (2020) Quantitative features and clinical significance of two subpopulations of AChR-specific CD4+ T cells in patients with myasthenia gravis. Clin Immunol 216:108462","DOI":"10.1016\/j.clim.2020.108462"},{"key":"10030_CR42","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.clim.2017.08.008","volume":"183","author":"M Luo","year":"2017","unstructured":"Luo M, Liu X, Meng H, Xu L, Li Y, Li Z, Liu C, Luo YB, Hu B, Xue Y, Liu Y, Luo Z, Yang H (2017) IFNA-AS1 regulates CD4+ T cell activation in myasthenia gravis though HLA-DRB1. Clin Immunol 183:121\u2013131","journal-title":"Clin Immunol"},{"issue":"5512","key":"10030_CR43","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1126\/science.1058867","volume":"291","author":"D Masopust","year":"2008","unstructured":"Masopust D, Vezys V, Marzo AL, Lefran\u00e7ois L (2008) Preferential localization of effector memory cells in nonlymphoid tissue. Science 291(5512):2413\u20132417","journal-title":"Science"},{"key":"10030_CR44","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1172\/JCI137786","volume":"130","author":"J Matthias","year":"2020","unstructured":"Matthias J, Heink S, Picard F, Zeitr\u00e4g J, Kolz A, Chao YY, Soll D, de Almeida GP, Glasmacher E, Jacobsen ID, Riedel T, Peters A, Floess S, Huehn J, Baumjohann D, Huber M, Korn T, Zielinski CE (2020) Salt generates antiinflammatory Th17 cells but amplifies pathogenicity in proinflammatory cytokine microenvironments. J Clin Invest 130:4587\u20134600","journal-title":"J Clin Invest"},{"issue":"11","key":"10030_CR46","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.4049\/jimmunol.149.11.3753","volume":"149","author":"T Miyawaki","year":"1992","unstructured":"Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachie A, Yonehara S, Taniguchi N (1992) Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 149(11):3753\u20133758","journal-title":"J Immunol"},{"issue":"8","key":"10030_CR47","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3390\/cells8080871","volume":"8","author":"J Monserrat","year":"2019","unstructured":"Monserrat J, Boh\u00f3rquez C, G\u00f3mez Lahoz AM, Movasat A, P\u00e9rez A, Ru\u00edz L, D\u00edaz D, Chara L, S\u00e1nchez AI, Albarr\u00e1n F, Sanz I, \u00c1lvarez-Mon M (2019) The Abnormal CD4+T Lymphocyte Subset Distribution and Vbeta Repertoire in New-onset Rheumatoid Arthritis Can Be Modulated by Methotrexate Treament. Cells 8(8):871","journal-title":"Cells"},{"issue":"3","key":"10030_CR48","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1074-7613(02)00391-6","volume":"17","author":"S Nakae","year":"2002","unstructured":"Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, Homma I, Sekikawa K, Asano M, Iwakura Y (2002) Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17(3):375\u2013387","journal-title":"Immunity"},{"issue":"11","key":"10030_CR49","doi-asserted-by":"publisher","first-page":"6173","DOI":"10.4049\/jimmunol.171.11.6173","volume":"171","author":"S Nakae","year":"2003","unstructured":"Nakae S, Nambu A, Sudo K, Iwakura Y (2003) Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171(11):6173\u20136177","journal-title":"J Immunol"},{"key":"10030_CR50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jneuroim.2017.06.001","volume":"310","author":"BR Nielsen","year":"2017","unstructured":"Nielsen BR, Ratzer R, B\u00f6rnsen L, von Essen MR, Christensen JR, Sellebjerg F (2017) Characterization of na\u00efve, memory and effector T cells in progressive multiple sclerosis. J Neuroimmunol 310:17\u201325","journal-title":"J Neuroimmunol"},{"issue":"4","key":"10030_CR51","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/cdd.2010.134","volume":"18","author":"M Paulsen","year":"2011","unstructured":"Paulsen M, Valentin S, Mathew B, Adam-Klages S, Bertsch U, Lavrik I, Krammer PH, Kabelitz D, Janssen O (2011) Modulation of CD4+ T-cell activation by CD95 co-stimulation. Cell Death Differ 18(4):619\u2013631","journal-title":"Cell Death Differ"},{"key":"10030_CR52","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/87687","volume":"2","author":"JM Penninger","year":"2001","unstructured":"Penninger JM (2001) CD45: new jobs for an old acquaitance. Nat Immunol 2:389\u2013396","journal-title":"Nat Immunol"},{"issue":"3","key":"10030_CR53","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cell.2007.04.031","volume":"129","author":"ME Peter","year":"2007","unstructured":"Peter ME, Budd RC, Desbarats J, Hedrick SM, Hueber AO, Newell MK, Owen LB, Pope RM, Tschopp J, Wajant H, Wallach D, Wiltrout RH, Z\u00f6rnig M, Lynch DH (2007) The CD95 receptor: apoptosis revisited. Cell 129(3):447\u2013450","journal-title":"Cell"},{"issue":"1","key":"10030_CR54","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/0961203317722848","volume":"27","author":"S Piantoni","year":"2018","unstructured":"Piantoni S, Regola F, Zanola A, Andreoli L, Dall\u2019Ara F, Tincani A, Airo\u2019 P (2018) Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes. Lupus 27(1):143\u2013149","journal-title":"Lupus"},{"issue":"1","key":"10030_CR55","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.immuni.2016.06.028","volume":"45","author":"A Poissonnier","year":"2016","unstructured":"Poissonnier A, Sans\u00e9au D, Le Gallo M, Malleter M, Levoin N, Viel R, Morere L, Penna A, Blanco P, Dupuy A, Poizeau F, Fautrel A, Seneschal J, Jouan F, Ritz J, Forcade E, Rioux N, Contin-Bordes C, Ducret T, Vacher AM, Barrow PA, Flynn RJ, Vacher P, Legembre P (2016) CD95-Mediated Calcium Signaling Promotes T Helper 17 Trafficking to Inflamed Organs in Lupus-Prone Mice. Immunity 45(1):209\u2013223","journal-title":"Immunity"},{"issue":"12","key":"10030_CR56","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/s41589-018-0162-9","volume":"14","author":"A Poissonnier","year":"2018","unstructured":"Poissonnier A, Gu\u00e9gan JP, Nguyen HT, Best D, Levoin N, Kozlov G, Gehring K, Pineau R, Jouan F, Morere L, Martin S, Thomas M, Lazaro E, Douchet I, Ducret T, van de Weghe P, Blanco P, Jean M, Vacher P, Legembre P (2018) Disrupting the CD95-PLC\u03b31 interaction prevents Th17-driven inflammation. Nat Chem Biol 14(12):1079\u20131089","journal-title":"Nat Chem Biol"},{"issue":"3","key":"10030_CR57","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3390\/cells9030531","volume":"9","author":"I Raphael","year":"2020","unstructured":"Raphael I, Joern RR, Forsthuber TG (2020) Memory CD4+ T Cells in Immunity and Autoimmune Diseases. Cells 9(3):531","journal-title":"Cells"},{"issue":"2","key":"10030_CR58","doi-asserted-by":"publisher","first-page":"194","DOI":"10.5114\/ceji.2018.77390","volume":"43","author":"W Ratajczak","year":"2018","unstructured":"Ratajczak W, Nied\u017awiedzka-Rystwej P, Tokarz-Deptu\u0142a B, Deptu\u0142a W (2018) Immunological memory cells. Cent Eur J Immunol 43(2):194\u2013203","journal-title":"Cent Eur J Immunol"},{"issue":"3","key":"10030_CR59","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1177\/1479164118817942","volume":"16","author":"S Rattik","year":"2019","unstructured":"Rattik S, Engelbertsen D, Wigren M, Ljungcrantz I, \u00d6stling G, Persson M, Nordin Fredrikson G, Bengtsson E, Nilsson J, Bj\u00f6rkbacka H (2019) Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease. Diab Vasc Dis Res 16(3):270\u2013280","journal-title":"Diab Vasc Dis Res"},{"key":"10030_CR60","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.coi.2017.10.001","volume":"49","author":"F Rieux-Laucat","year":"2017","unstructured":"Rieux-Laucat F (2017) What\u2019s up in the ALPS. Curr Opin Immunol 49:79\u201386","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"10030_CR61","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s10875-018-0523-x","volume":"38","author":"F Rieux-Laucat","year":"2018","unstructured":"Rieux-Laucat F, Mag\u00e9rus-Chatinet A, Neven B (2018) The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions. J Clin Immunol 38(5):558\u2013568","journal-title":"J Clin Immunol"},{"issue":"2","key":"10030_CR62","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/mus.22070","volume":"44","author":"JC Roche","year":"2011","unstructured":"Roche JC, Capablo JL, Larrad L, Gervas-Arruga J, Ara JR, S\u00e1nchez A, Alarcia R (2011) Increased serum interleukin-17 levels in patients with myasthenia gravis. Muscle Nerve 44(2):278\u2013280","journal-title":"Muscle Nerve"},{"key":"10030_CR63","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","volume":"22","author":"F Sallusto","year":"2004","unstructured":"Sallusto F, Geginat J, Lanzavecchia A (2004) Central Memory and Effector Memory T Cell Subsets: Function, Generation, and Maintenance. Annu Rev Immunol 22:745\u2013763","journal-title":"Annu Rev Immunol"},{"key":"10030_CR64","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/44385","volume":"401","author":"F Sallusto","year":"1999","unstructured":"Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708\u2013712","journal-title":"Nature"},{"issue":"4","key":"10030_CR65","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","volume":"87","author":"DB Sanders","year":"2016","unstructured":"Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, Kuntz N, Massey JM, Melms A, Murai H, Nicolle M, Palace J, Richman DP, Verschuuren J, Narayanaswami P (2016) International consensus guidance for management of myasthenia gravis: Executive summary. Neurology 87(4):419\u2013425","journal-title":"Neurology"},{"issue":"5","key":"10030_CR66","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/eji.201445064","volume":"45","author":"H Schaffert","year":"2015","unstructured":"Schaffert H, Pelz A, Saxena A, Losen M, Meisel A, Thiel A, Kohler S (2015) IL-17-producing CD4(+) T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis. Eur J Immunol 45(5):1339\u20131347","journal-title":"Eur J Immunol"},{"issue":"1","key":"10030_CR67","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1038\/s41467-019-10889-4","volume":"10","author":"Y Shen","year":"2019","unstructured":"Shen Y, Song Z, Lu X, Ma Z, Lu C, Zhang B, Chen Y, Duan M, Apetoh L, Li X, Guo J, Miao Y, Zhang G, Yang D, Cai Z, Wang J (2019) Fas signaling-mediated TH9 cell differentiation favors bowel inflammation and antitumor functions. Nat Commun 10(1):2924","journal-title":"Nat Commun"},{"issue":"7","key":"10030_CR68","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.4049\/jimmunol.179.7.4397","volume":"179","author":"SL Shiao","year":"2007","unstructured":"Shiao SL, Kirkiles-Smith NC, Shepherd BR, McNiff JM, Carr EJ, Pober JS (2007) Human effector memory CD4+ T cells directly recognize allogeneic endothelial cells in vitro and in vivo. J Immunol 179(7):4397\u20134404","journal-title":"J Immunol"},{"issue":"7","key":"10030_CR69","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1468-1331.2006.01476.x","volume":"13","author":"GO Skeie","year":"2006","unstructured":"Skeie GO, Apostolski S, Evoli A, Gilhus NE, Hart IK, Harms L, Hilton-Jones D, Melms A, Verschuuren J, Horge HW (2006) Guidelines for the treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol 13(7):691\u2013699","journal-title":"Eur J Neurol"},{"key":"10030_CR70","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.immuni.2009.01.001","volume":"30","author":"A Strasser","year":"2009","unstructured":"Strasser A, Jost PJ, Nagata S (2009) The many roles of FAS receptor signaling in the immune system. Immunity 30:180\u2013192","journal-title":"Immunity"},{"issue":"9","key":"10030_CR71","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.4049\/jimmunol.1502641","volume":"197","author":"B Subbarayal","year":"2016","unstructured":"Subbarayal B, Chauhan SK, Di Zazzo A, Dana R (2016) IL-17 Augments B Cell Activation in Ocular Surface Autoimmunity. J Immunol 197(9):3464\u20133470","journal-title":"J Immunol"},{"issue":"6","key":"10030_CR72","doi-asserted-by":"publisher","first-page":"8863","DOI":"10.3892\/mmr.2017.7689","volume":"16","author":"Q Tan","year":"2017","unstructured":"Tan Q, Yang H, Liu E, Wang H (2017) P38\/ERK MAPK signaling pathways are involved in the regulation of filaggrin and involucrin by IL-17. Mol Med Rep 16(6):8863\u20138867","journal-title":"Mol Med Rep"},{"key":"10030_CR73","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.3389\/fimmu.2019.02500","volume":"10","author":"V Upasani","year":"2019","unstructured":"Upasani V, Vo HTM, Ung S, Heng S, Laurent D, Choeung R, Duong V, Sorn S, Ly S, Rodenhuis-Zybert IA, Dussart P, Cantaert T (2019) Impaired Antibody-Independent Immune Response of B Cells in Patients With Acute Dengue Infection. Front Immunol 10:2500","journal-title":"Front Immunol"},{"issue":"3","key":"10030_CR74","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1212\/WNL.52.3.484","volume":"52","author":"ZY Wang","year":"1999","unstructured":"Wang ZY, Karachunski PI, Howard JF Jr, Conti-Fine BM (1999) Myasthenia in SCID mice grafted with myasthenic patient lymphocytes: role of CD4+ and CD8+ cells. Neurology 52(3):484\u2013497","journal-title":"Neurology"},{"key":"10030_CR75","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.3389\/fimmu.2018.02521","volume":"9","author":"JW Williams","year":"2018","unstructured":"Williams JW, Ferreira CM, Blaine KM, Rayon C, Vel\u00e1zquez F, Tong J, Peter ME, Sperling AI (2018) Non-apoptotic Fas (CD95) signaling on T cells regulates the resolution of Th2-mediated inflammation. Front Immunol 9:2521","journal-title":"Front Immunol"},{"issue":"2","key":"10030_CR76","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.cellsig.2009.09.016","volume":"22","author":"P Wisniewski","year":"2010","unstructured":"Wisniewski P, Ellert-Miklaszewska A, Kwiatkowska A, Kaminska B (2010) Non-apoptotic Fas signaling regulates invasiveness of glioma cells and modulates MMP-2 activity via NFkappaB-TIMP-2 pathway. Cell Signal 22(2):212\u2013220","journal-title":"Cell Signal"},{"issue":"7446","key":"10030_CR77","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature11981","volume":"496","author":"N Yosef","year":"2013","unstructured":"Yosef N, Shalek AK, Gaublomme JT, Jin H, Lee Y, Awasthi A, Wu C, Karwacz K, Xiao S, Jorgolli M, Gennert D, Satija R, Shakya A, Lu DY, Trombetta JJ, Pillai MR, Ratcliffe PJ, Coleman ML, Bix M, Tantin D, Park H, Kuchroo VK, Regev A (2013) Dynamic regulatory network controlling TH17 cell differentiation. Nature 496(7446):461\u2013468","journal-title":"Nature"},{"issue":"4","key":"10030_CR78","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/archneurol.2011.2393","volume":"69","author":"B Zhang","year":"2012","unstructured":"Zhang B, Tzartos JS, Belimezi M, Ragheb S, Bealmear B, Lewis RA, Xiong WC, Lisak RP, Tzartos SJ, Mei L (2012) Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis. Arch Neurol 69(4):445\u2013451","journal-title":"Arch Neurol"},{"issue":"5\u20136","key":"10030_CR79","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1007\/s12026-016-8872-0","volume":"64","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Zhang X, Xia Y, Jia X, Li H, Zhang Y, Shao Z, Xin N, Guo M, Chen J, Zheng S, Wang Y, Fu L, Xiao C, Geng D, Liu Y, Cui G, Dong R, Huang X, Yu T (2016) CD19+ Tim-1+ B cells are decreased and negatively correlated with disease severity in Myasthenia Gravis patients. Immunol Res 64(5\u20136):1216\u20131224","journal-title":"Immunol Res"},{"issue":"4","key":"10030_CR80","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s11481-015-9638-5","volume":"10","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Shao Z, Zhang X, Jia X, Xia Y, Zhang Y, Xin N, Guo M, Chen J, Zheng S, Wang Y, Fu L, Dong R, Xiao C, Geng D, Liu Y (2015) TIPE2 Play a Negative Role in TLR4-Mediated Autoimmune T Helper 17 Cell Responses in Patients with Myasthenia Gravis. J Neuroimmune Pharmacol 10(4):635\u2013644","journal-title":"J Neuroimmune Pharmacol"},{"issue":"3","key":"10030_CR45","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.immuni.2018.03.008","volume":"48","author":"MG Zu Horste","year":"2018","unstructured":"Zu Horste MG, Przybylski D, Schramm MA, Wang C, Schnell A`, Lee Y, Sobel R, Regev A, Kuchroo VK (2018) Fas Promotes T Helper 17 Cell Differentiation and Inhibits T Helper 1 Cell Development by Binding and Sequestering Transcription Factor STAT1. Immunity 48(3):556\u2013569","journal-title":"Immunity"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-021-10030-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11481-021-10030-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-021-10030-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T02:06:47Z","timestamp":1673143607000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11481-021-10030-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":80,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10030"],"URL":"https:\/\/doi.org\/10.1007\/s11481-021-10030-7","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,29]]},"assertion":[{"value":"12 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of Affiliated Hospital of Xuzhou Medical University approved the study protocol. Written consent was obtained from all study participants or their immediate family members.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors have no financial conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}